Clinical Trial Update: TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing TPF plus cisplatin and radiotherapy versus TPF plus cetuximab and radiotherapy for head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• TPF + cetuximab + radiotherapy
• TPF + cisplatin + radiotherapy

Snippet

Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | Conditions: Head and Neck Cancer | Phase 3 | Status: COMPLETED